• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bayer AG

Bayer AG

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Bayer Halts Phase 3 Study on New Xarelto Indication

    Bayer Halts Phase 3 Study on New Xarelto Indication

  2. Hematoma Global Clinical Trials Review, H2, 2017 - Research and Markets

    Hematoma Global Clinical Trials Review, H2, 2017 - Research and Markets

  3. Global Medical Imaging Reagents Market 2017: By Class Type, Technology & Application - Research and Markets

    Global Medical Imaging Reagents Market 2017: By Class Type, Technology & Application - Research and Markets

  4. Global Detergents Market - Trends & Forecasts (2017-2022) - Research and Markets

    Global Detergents Market - Trends & Forecasts (2017-2022) - Research and Markets

  5. Bayer agrees $7 billion sale of assets to BASF, in aid of Monsanto megadeal

    Bayer agrees $7 billion sale of assets to BASF, in aid of Monsanto megadeal

  6. BASF to Buy Large Parts of Bayer's Seed and Non-Selective Herbicide Businesses

    BASF to Buy Large Parts of Bayer's Seed and Non-Selective Herbicide Businesses

  7. UPDATE: Johnson & Johnson earnings: All eyes on hurricane impact

    UPDATE: Johnson & Johnson earnings: All eyes on hurricane impact

  8. Bayer Reduces Covestro Stake, Will Revise Outlook Accordingly

    Bayer Reduces Covestro Stake, Will Revise Outlook Accordingly

  9. UPDATE: U.S. stocks reach for higher open, with inflation and big bank earnings in focus

    UPDATE: U.S. stocks reach for higher open, with inflation and big bank earnings in focus

  10. MARKET SNAPSHOT: U.S. Stocks Reach For Higher Open, With Inflation And Big Bank Earnings In Focus

    MARKET SNAPSHOT: U.S. Stocks Reach For Higher Open, With Inflation And Big Bank Earnings In Focus

12345

©2017 Morningstar Advisor. All right reserved.